We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Trade like a pro: Leverage real-time discussions and market-moving ideas to outperform.
The current CYCN market cap is 9.21M. The company's latest EPS is USD -1.9420 and P/E is -1.64.
| Quarter End | Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 |
|---|---|---|---|---|---|
| USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
| Total Revenue | 0 | 0 | 0 | 0 | 0 |
| Operating Income | -4.24M | 3.43M | -1.8M | -1.62M | -1.38M |
| Net Income | -4.18M | 7.57M | -1.69M | -1.54M | -1.32M |
| Year End December 30 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
| Total Revenue | 4.51M | 3.97M | 3.94M | 1.63M | 0 |
| Operating Income | -125.04M | -81.27M | -55.2M | -44.37M | -9.65M |
| Net Income | -123.01M | -77.8M | -51.65M | -44.08M | -5.26M |
| Quarter End | Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 |
|---|---|---|---|---|---|
| USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
| Total Assets | 10.1M | 15.21M | 13.37M | 11.36M | 10.07M |
| Total Liabilities | 4.95M | 2.34M | 2.09M | 1.44M | 1.28M |
| Total Equity | 5.15M | 12.87M | 11.29M | 9.92M | 8.78M |
| Year End December 30 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
| Total Assets | 186.48M | 115.38M | 59.33M | 18.08M | 13.37M |
| Total Liabilities | 88.75M | 55.89M | 11.09M | 7.63M | 2.09M |
| Total Equity | 97.73M | 59.49M | 48.25M | 10.45M | 11.29M |
| Quarter End | Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 |
|---|---|---|---|---|---|
| USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
| Operating | -12.77M | -19.7M | -21.25M | -1.87M | -2.98M |
| Investing | N/A | 10.4M | 10.4M | N/A | N/A |
| Financing | 5.02M | 5.02M | 5.02M | N/A | N/A |
| Year End December 30 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
| Operating | -102.22M | -72.49M | -36.52M | -40.61M | -21.25M |
| Investing | -6.72M | 18k | 1.46M | N/A | 10.4M |
| Financing | 211.57M | 28.09M | 30.79M | 29k | 5.02M |
| Market Cap | 9.21M |
| Price to Earnings Ratio | -1.64 |
| Price to Sales Ratio | 0 |
| Price to Cash Ratio | 1.14 |
| Price to Book Ratio | 0.77 |
| Dividend Yield | - |
| Shares Outstanding | 2.71M |
| Average Volume (1 week) | 241.28k |
| Average Volume (1 Month) | 9.05M |
| 52 Week Change | -30.33% |
| 52 Week High | 9.4699 |
| 52 Week Low | 1.27 |
| Spread (Intraday) | 3.13 (65.48%) |
| Company Name | Cyclerion Therapeutics Inc |
| Address |
155 federal street boston, massachusetts 02110 |
| Website | https://www.cyclerion.com |
| Industry | pharmaceutical preparations (2834) |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: 1-888-992-3836 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
Hot Features
Premium
